EN DE

HealthCo Healthcare & Wellness REIT (HCW) (HCW) Fair Value & Analysis

Real Estate · AU · Market cap A$393M

HH HealthCo Healthcare & Wellness REIT (HCW) HCW · AU
PriceA$0.7400
Fair ValueA$0.5500
Upside-25.7%
Quality41/100
Watch HealthCo Healthcare & Wellness REIT (HCW) for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -162.6% net margin
Low debt · generates free cash flow
Mixed vs. peers (6/11)
Narrow moat 39/100
Evidence: High Range A$0.4100 – A$0.7400 Share as image

Fair value as of: Jul 20, 2026

From 13 valuation models · updated 21 days ago

Share price +7.2% over the past month.

Below-average quality, and screening another 26% overvalued on our models.

What matters now

  • Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • A fairly wide model range (A$0.4100 to A$0.7400) leaves room in how you read the outcome.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

A$1.93 A$0.6050 Fair Value A$0.5500 Sep 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.

How to read this chart

59‑month range A$0.6050 – A$1.93 · fair‑value band A$0.4100 – A$0.7400 · the A$0.7400 price screens above the A$0.5500 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

HealthCo Healthcare & Wellness REIT (HCW) (HCW) currently trades at A$0.7400, while our model-based Fair Value estimate is A$0.5500, implying the stock looks roughly 25.7% overvalued today. The Quality Score stands at 41/100 (below-average quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Trailing-twelve-month revenue stands at A$61.7M. Revenue grew 4.6% year over year. It earns a return on equity of -12.3%. Net debt stands at A$408M. Fundamentals as of Jul 20, 2026

Our scenario range runs from A$0.4100 (bear case) to A$0.7400 (bull case); at A$0.7400, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 14% below its 52-week high and 23% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -53% fair-value upside, at -26%, HCW screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF A$0.3900 A$0.5100 A$0.6600 80
Rev-Margin DCF A$0.4700 A$0.7200 A$1.00 74
Gordon GGM A$0.4900 A$0.8800 A$1.21 70
All 13 models by family
DCF Models
FCF DCF A$0.3900 A$0.5300 A$0.7200 38
5Y Revenue Exit A$0.4700 A$0.7200 A$1.04 39
5Y EBITDA Exit A$0.6300 A$1.03 A$1.49 41
10Y Revenue Exit A$0.4200 A$0.6200 A$0.9000 36
10Y EBITDA Exit A$0.5300 A$0.8200 A$1.22 37
Dividend Discount
Gordon GGM A$0.4900 A$0.8800 A$1.21 70
DDM Multi-Stage A$0.4900 A$0.7600 A$0.9400 61
Multiples
EV/EBIT A$1.07 A$1.40 A$1.73 53
EV/EBITDA A$0.8900 A$1.17 A$1.44 54
EV/Revenue A$0.5500 A$0.7500 A$0.9500 43
Asset-Based
NCAV (Graham) A$0.7200 A$0.9600 A$1.43 50
Growth DCF
Growth DCF A$0.3900 A$0.5100 A$0.6600 80
Rev-Margin DCF A$0.4700 A$0.7200 A$1.00 74

Widest divergence: Multiples (A$1.17) versus Growth DCF (A$0.5100). Highest evidence: Growth DCF (80).

Notify me when HCW reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) A$61.7M
Revenue growth (YoY) +4.6%
Net margin -163%
Return on equity -12.3%
Free cash flow A$18.3M FY2025
Operating margin 75.0%
More key figures
EPS (TTM) A$-0.1800
EPS growth (YoY) -53.1%
Net debt A$408M FY2025

Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 41/100

Of which business quality 45 · Market factors (momentum, volatility) 50

Profitability 1
Margins and returns on capital today
Quality Growth 10
Are margins and returns improving?
Cashflow 100
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 56
Disciplined investing over empire-building
Low Volatility 68
Calm price path (market factor)
Momentum 43
Price trend over the last 3–12 months (market factor)
52W Momentum 40
Distance to the 52-week high (market factor)
Net Issuance 50
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

HealthCo Healthcare & Wellness REIT (HCW) is a Real Estate Investment Trust listed on the ASX focused on owning healthcare and wellness property assets.

Full company description

HealthCo Healthcare & Wellness REIT (HCW) is a Real Estate Investment Trust listed on the ASX focused on owning healthcare and wellness property assets. The REIT's objective is to provide exposure to a diversified portfolio underpinned by healthcare sector megatrends, targeting stable and growing distributions, long-term capital growth and positive environmental and social impact. HCW is Australia's leading diversified healthcare REIT with a combined portfolio size of 1.4 billion US dollars. HealthCo Healthcare and Wellness REIT was incorporated on July 30th, 2021 in Australia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

HealthCo Healthcare & Wellness REIT (HCW) reported revenue of A$53.0M in FY2025 versus A$24.5M in FY2022, a compound +29.4%/yr. Reported net income was −A$88.8M in FY2025.

Growth Quality 61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
A$53.0M
Latest YoY
−17.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+29.4%
Revenue +29.4%/yr
FY22 A$24.5M
FY23 A$40.2M
FY24 A$64.0M
FY25 A$53.0M
Net income
FY22 A$49.6M
FY23 A$20.2M
FY24 A$6.9M
FY25 −A$88.8M

HCW screens 26% overvalued. Compare with Welltower Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "HealthCo Healthcare & Wellness REIT (HCW) Fair Value". https://www.fairvalue-calculator.com/stock/HCW

Peer Group

REIT - Healthcare Facilities · 28 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 43 · Below median
Fair Value upside −26% · Above median
Return on assets 2% · Below median
Net margin (TTM) -163% · Bottom 25%
Operating margin (TTM) 75% · Above median
Revenue growth 5% · Below median

Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper

P/B 0.35× · Cheaper than 75% of peers
P/S (TTM) 4.50× · Cheaper than median
P/FCF 15.2× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 23 · sector 30
PAST 0 · sector 21
HEALTH 100 · sector 71
DIVIDEND 0 · sector 100

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).

Stock Price Fair Value vs Fair Value
Welltower Inc WELL $231.59 $42.21 -82%
Ventas, Inc VTR $100.53 $18.07 -82%
Omega Healthcare Investors, Inc OHI $47.39 $33.54 -29%
Healthpeak Properties, Inc DOC $22.27 $7.02 -68%
American Healthcare REIT, Inc AHR $56.38 $11.04 -80%
CareTrust REIT, Inc CTRE $43.25 $23.07 -47%
Healthcare Realty Trust Incorporated HR $21.40 $20.60 -4%
Aedifica NV AED €69.85 €36.17 -48%
Chartwell Retirement Residences CSHUN C$22.81 C$3.52 -85%
Sabra Health Care REIT, Inc SBRA $22.36 $10.49 -53%

Compare HealthCo Healthcare & Wellness REIT (HCW) with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is HealthCo Healthcare & Wellness REIT (HCW) (HCW) overvalued or undervalued?
As of Jul 20, 2026, our model estimates a fair value of A$0.5500 versus a price of A$0.7400, about −26% (overvalued).
What is the fair value of HCW?
Our model-based fair value for HealthCo Healthcare & Wellness REIT (HCW) is A$0.5500 (as of Jul 20, 2026), built from audited fundamentals. The current price is A$0.7400.
What is the quality score of HCW?
HealthCo Healthcare & Wellness REIT (HCW) has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of HealthCo Healthcare & Wellness REIT (HCW) (HCW)?
HealthCo Healthcare & Wellness REIT (HCW) reported trailing-twelve-month revenue of about A$61.7M (latest available figure, as of Jul 20, 2026).
What is the net profit margin of HCW?
The net profit margin of HealthCo Healthcare & Wellness REIT (HCW) is about -162.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track HealthCo Healthcare & Wellness REIT (HCW) and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.